0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cas12 Nuclease Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-0Z13283
Home | Market Reports | Science
Global Cas Nuclease Market Research Report 2023
BUY CHAPTERS

Global Cas12 Nuclease Market Research Report 2026

Code: QYRE-Auto-0Z13283
Report
2026-01-30
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cas12 Nuclease Market

The global Cas12 Nuclease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cas12 Nuclease competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cas12 nuclease is a type of RNA-guided enzyme derived from the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) system. It functions as a programmable endonuclease that can recognize and cleave double-stranded DNA at specific sites guided by a single RNA molecule, known as CRISPR RNA (crRNA). Cas12 is notable for its collateral cleavage activity, allowing it to cut nearby single-stranded DNA, making it useful for various applications in gene editing, diagnostics, and synthetic biology.
The North American market for Cas12 Nuclease is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cas12 Nuclease is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Cas12 Nuclease include Integrated DNA Technologies, Synthego, Danaher, GenScript, Sigma-Aldrich, Signalchem, BPS Bioscience, New England Biolabs, Intact Genomics, Molecular Cloning Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cas12 Nuclease market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cas12 Nuclease. The Cas12 Nuclease market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cas12 Nuclease market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cas12 Nuclease manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cas12 Nuclease Market Report

Report Metric Details
Report Name Cas12 Nuclease Market
Segment by Type
  • Cas12a
  • Cas12b
  • Other
by Application
  • Academic & Research Institutes
  • Biopharmaceutical
  • Hospitals & Diagnostic Centers
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Integrated DNA Technologies, Synthego, Danaher, GenScript, Sigma-Aldrich, Signalchem, BPS Bioscience, New England Biolabs, Intact Genomics, Molecular Cloning Laboratories, Yeasen Biotechnology, Beyotime Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Cas12 Nuclease manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Cas12 Nuclease sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Cas12 Nuclease Market report?

Ans: The main players in the Cas12 Nuclease Market are Integrated DNA Technologies, Synthego, Danaher, GenScript, Sigma-Aldrich, Signalchem, BPS Bioscience, New England Biolabs, Intact Genomics, Molecular Cloning Laboratories, Yeasen Biotechnology, Beyotime Biotech

What are the Application segmentation covered in the Cas12 Nuclease Market report?

Ans: The Applications covered in the Cas12 Nuclease Market report are Academic & Research Institutes, Biopharmaceutical, Hospitals & Diagnostic Centers, Other

What are the Type segmentation covered in the Cas12 Nuclease Market report?

Ans: The Types covered in the Cas12 Nuclease Market report are Cas12a, Cas12b, Other

1 Cas12 Nuclease Market Overview
1.1 Product Definition
1.2 Cas12 Nuclease by Type
1.2.1 Global Cas12 Nuclease Market Value by Type: 2025 vs 2032
1.2.2 Cas12a
1.2.3 Cas12b
1.2.4 Other
1.3 Cas12 Nuclease by Application
1.3.1 Global Cas12 Nuclease Market Value by Application: 2025 vs 2032
1.3.2 Academic & Research Institutes
1.3.3 Biopharmaceutical
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Other
1.4 Global Cas12 Nuclease Market Size Estimates and Forecasts
1.4.1 Global Cas12 Nuclease Revenue 2021–2032
1.4.2 Global Cas12 Nuclease Sales 2021–2032
1.4.3 Global Cas12 Nuclease Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cas12 Nuclease Market Competition by Manufacturers
2.1 Global Cas12 Nuclease Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cas12 Nuclease Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cas12 Nuclease Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cas12 Nuclease, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cas12 Nuclease, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cas12 Nuclease, Product Types and Applications
2.7 Global Key Manufacturers of Cas12 Nuclease, Date of Entry into the Industry
2.8 Global Cas12 Nuclease Market Competitive Situation and Trends
2.8.1 Global Cas12 Nuclease Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cas12 Nuclease Players Market Share by Revenue
2.8.3 Global Cas12 Nuclease Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cas12 Nuclease Market Scenario by Region
3.1 Global Cas12 Nuclease Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cas12 Nuclease Sales by Region: 2021–2032
3.2.1 Global Cas12 Nuclease Sales by Region: 2021–2026
3.2.2 Global Cas12 Nuclease Sales by Region: 2027–2032
3.3 Global Cas12 Nuclease Revenue by Region: 2021–2032
3.3.1 Global Cas12 Nuclease Revenue by Region: 2021–2026
3.3.2 Global Cas12 Nuclease Revenue by Region: 2027–2032
3.4 North America Cas12 Nuclease Market Facts & Figures by Country
3.4.1 North America Cas12 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cas12 Nuclease Sales by Country (2021–2032)
3.4.3 North America Cas12 Nuclease Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cas12 Nuclease Market Facts & Figures by Country
3.5.1 Europe Cas12 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cas12 Nuclease Sales by Country (2021–2032)
3.5.3 Europe Cas12 Nuclease Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cas12 Nuclease Market Facts & Figures by Region
3.6.1 Asia Pacific Cas12 Nuclease Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cas12 Nuclease Sales by Region (2021–2032)
3.6.3 Asia Pacific Cas12 Nuclease Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cas12 Nuclease Market Facts & Figures by Country
3.7.1 Latin America Cas12 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cas12 Nuclease Sales by Country (2021–2032)
3.7.3 Latin America Cas12 Nuclease Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cas12 Nuclease Market Facts & Figures by Country
3.8.1 Middle East and Africa Cas12 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cas12 Nuclease Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cas12 Nuclease Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cas12 Nuclease Sales by Type (2021–2032)
4.1.1 Global Cas12 Nuclease Sales by Type (2021–2026)
4.1.2 Global Cas12 Nuclease Sales by Type (2027–2032)
4.1.3 Global Cas12 Nuclease Sales Market Share by Type (2021–2032)
4.2 Global Cas12 Nuclease Revenue by Type (2021–2032)
4.2.1 Global Cas12 Nuclease Revenue by Type (2021–2026)
4.2.2 Global Cas12 Nuclease Revenue by Type (2027–2032)
4.2.3 Global Cas12 Nuclease Revenue Market Share by Type (2021–2032)
4.3 Global Cas12 Nuclease Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cas12 Nuclease Sales by Application (2021–2032)
5.1.1 Global Cas12 Nuclease Sales by Application (2021–2026)
5.1.2 Global Cas12 Nuclease Sales by Application (2027–2032)
5.1.3 Global Cas12 Nuclease Sales Market Share by Application (2021–2032)
5.2 Global Cas12 Nuclease Revenue by Application (2021–2032)
5.2.1 Global Cas12 Nuclease Revenue by Application (2021–2026)
5.2.2 Global Cas12 Nuclease Revenue by Application (2027–2032)
5.2.3 Global Cas12 Nuclease Revenue Market Share by Application (2021–2032)
5.3 Global Cas12 Nuclease Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Integrated DNA Technologies
6.1.1 Integrated DNA Technologies Company Information
6.1.2 Integrated DNA Technologies Description and Business Overview
6.1.3 Integrated DNA Technologies Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Integrated DNA Technologies Cas12 Nuclease Product Portfolio
6.1.5 Integrated DNA Technologies Recent Developments/Updates
6.2 Synthego
6.2.1 Synthego Company Information
6.2.2 Synthego Description and Business Overview
6.2.3 Synthego Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Synthego Cas12 Nuclease Product Portfolio
6.2.5 Synthego Recent Developments/Updates
6.3 Danaher
6.3.1 Danaher Company Information
6.3.2 Danaher Description and Business Overview
6.3.3 Danaher Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Danaher Cas12 Nuclease Product Portfolio
6.3.5 Danaher Recent Developments/Updates
6.4 GenScript
6.4.1 GenScript Company Information
6.4.2 GenScript Description and Business Overview
6.4.3 GenScript Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 GenScript Cas12 Nuclease Product Portfolio
6.4.5 GenScript Recent Developments/Updates
6.5 Sigma-Aldrich
6.5.1 Sigma-Aldrich Company Information
6.5.2 Sigma-Aldrich Description and Business Overview
6.5.3 Sigma-Aldrich Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sigma-Aldrich Cas12 Nuclease Product Portfolio
6.5.5 Sigma-Aldrich Recent Developments/Updates
6.6 Signalchem
6.6.1 Signalchem Company Information
6.6.2 Signalchem Description and Business Overview
6.6.3 Signalchem Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Signalchem Cas12 Nuclease Product Portfolio
6.6.5 Signalchem Recent Developments/Updates
6.7 BPS Bioscience
6.7.1 BPS Bioscience Company Information
6.7.2 BPS Bioscience Description and Business Overview
6.7.3 BPS Bioscience Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 BPS Bioscience Cas12 Nuclease Product Portfolio
6.7.5 BPS Bioscience Recent Developments/Updates
6.8 New England Biolabs
6.8.1 New England Biolabs Company Information
6.8.2 New England Biolabs Description and Business Overview
6.8.3 New England Biolabs Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 New England Biolabs Cas12 Nuclease Product Portfolio
6.8.5 New England Biolabs Recent Developments/Updates
6.9 Intact Genomics
6.9.1 Intact Genomics Company Information
6.9.2 Intact Genomics Description and Business Overview
6.9.3 Intact Genomics Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Intact Genomics Cas12 Nuclease Product Portfolio
6.9.5 Intact Genomics Recent Developments/Updates
6.10 Molecular Cloning Laboratories
6.10.1 Molecular Cloning Laboratories Company Information
6.10.2 Molecular Cloning Laboratories Description and Business Overview
6.10.3 Molecular Cloning Laboratories Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Molecular Cloning Laboratories Cas12 Nuclease Product Portfolio
6.10.5 Molecular Cloning Laboratories Recent Developments/Updates
6.11 Yeasen Biotechnology
6.11.1 Yeasen Biotechnology Company Information
6.11.2 Yeasen Biotechnology Description and Business Overview
6.11.3 Yeasen Biotechnology Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Yeasen Biotechnology Cas12 Nuclease Product Portfolio
6.11.5 Yeasen Biotechnology Recent Developments/Updates
6.12 Beyotime Biotech
6.12.1 Beyotime Biotech Company Information
6.12.2 Beyotime Biotech Description and Business Overview
6.12.3 Beyotime Biotech Cas12 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Beyotime Biotech Cas12 Nuclease Product Portfolio
6.12.5 Beyotime Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cas12 Nuclease Industry Chain Analysis
7.2 Cas12 Nuclease Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cas12 Nuclease Production Mode & Process Analysis
7.4 Cas12 Nuclease Sales and Marketing
7.4.1 Cas12 Nuclease Sales Channels
7.4.2 Cas12 Nuclease Distributors
7.5 Cas12 Nuclease Customer Analysis
8 Cas12 Nuclease Market Dynamics
8.1 Cas12 Nuclease Industry Trends
8.2 Cas12 Nuclease Market Drivers
8.3 Cas12 Nuclease Market Challenges
8.4 Cas12 Nuclease Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cas12 Nuclease Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cas12 Nuclease Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Cas12 Nuclease Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Cas12 Nuclease Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Cas12 Nuclease Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Cas12 Nuclease Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Cas12 Nuclease Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Cas12 Nuclease Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Cas12 Nuclease, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Cas12 Nuclease, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Cas12 Nuclease, Product Types and Applications
 Table 12. Global Key Manufacturers of Cas12 Nuclease, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cas12 Nuclease Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cas12 Nuclease Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cas12 Nuclease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Cas12 Nuclease Sales by Region (K Units), 2021–2026
 Table 18. Global Cas12 Nuclease Sales Market Share by Region (2021–2026)
 Table 19. Global Cas12 Nuclease Sales by Region (K Units), 2027–2032
 Table 20. Global Cas12 Nuclease Sales Market Share by Region (2027–2032)
 Table 21. Global Cas12 Nuclease Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Cas12 Nuclease Revenue Market Share by Region (2021–2026)
 Table 23. Global Cas12 Nuclease Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Cas12 Nuclease Revenue Market Share by Region (2027–2032)
 Table 25. North America Cas12 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Cas12 Nuclease Sales by Country (K Units), 2021–2026
 Table 27. North America Cas12 Nuclease Sales by Country (K Units), 2027–2032
 Table 28. North America Cas12 Nuclease Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Cas12 Nuclease Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Cas12 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Cas12 Nuclease Sales by Country (K Units), 2021–2026
 Table 32. Europe Cas12 Nuclease Sales by Country (K Units), 2027–2032
 Table 33. Europe Cas12 Nuclease Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Cas12 Nuclease Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Cas12 Nuclease Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Cas12 Nuclease Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Cas12 Nuclease Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Cas12 Nuclease Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Cas12 Nuclease Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Cas12 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Cas12 Nuclease Sales by Country (K Units), 2021–2026
 Table 42. Latin America Cas12 Nuclease Sales by Country (K Units), 2027–2032
 Table 43. Latin America Cas12 Nuclease Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Cas12 Nuclease Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Cas12 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Cas12 Nuclease Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Cas12 Nuclease Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Cas12 Nuclease Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Cas12 Nuclease Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Cas12 Nuclease Sales (K Units) by Type (2021–2026)
 Table 51. Global Cas12 Nuclease Sales (K Units) by Type (2027–2032)
 Table 52. Global Cas12 Nuclease Sales Market Share by Type (2021–2026)
 Table 53. Global Cas12 Nuclease Sales Market Share by Type (2027–2032)
 Table 54. Global Cas12 Nuclease Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Cas12 Nuclease Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Cas12 Nuclease Revenue Market Share by Type (2021–2026)
 Table 57. Global Cas12 Nuclease Revenue Market Share by Type (2027–2032)
 Table 58. Global Cas12 Nuclease Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Cas12 Nuclease Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Cas12 Nuclease Sales (K Units) by Application (2021–2026)
 Table 61. Global Cas12 Nuclease Sales (K Units) by Application (2027–2032)
 Table 62. Global Cas12 Nuclease Sales Market Share by Application (2021–2026)
 Table 63. Global Cas12 Nuclease Sales Market Share by Application (2027–2032)
 Table 64. Global Cas12 Nuclease Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Cas12 Nuclease Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Cas12 Nuclease Revenue Market Share by Application (2021–2026)
 Table 67. Global Cas12 Nuclease Revenue Market Share by Application (2027–2032)
 Table 68. Global Cas12 Nuclease Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Cas12 Nuclease Price (US$/Unit) by Application (2027–2032)
 Table 70. Integrated DNA Technologies Company Information
 Table 71. Integrated DNA Technologies Description and Business Overview
 Table 72. Integrated DNA Technologies Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Integrated DNA Technologies Cas12 Nuclease Product
 Table 74. Integrated DNA Technologies Recent Developments/Updates
 Table 75. Synthego Company Information
 Table 76. Synthego Description and Business Overview
 Table 77. Synthego Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Synthego Cas12 Nuclease Product
 Table 79. Synthego Recent Developments/Updates
 Table 80. Danaher Company Information
 Table 81. Danaher Description and Business Overview
 Table 82. Danaher Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Danaher Cas12 Nuclease Product
 Table 84. Danaher Recent Developments/Updates
 Table 85. GenScript Company Information
 Table 86. GenScript Description and Business Overview
 Table 87. GenScript Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. GenScript Cas12 Nuclease Product
 Table 89. GenScript Recent Developments/Updates
 Table 90. Sigma-Aldrich Company Information
 Table 91. Sigma-Aldrich Description and Business Overview
 Table 92. Sigma-Aldrich Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Sigma-Aldrich Cas12 Nuclease Product
 Table 94. Sigma-Aldrich Recent Developments/Updates
 Table 95. Signalchem Company Information
 Table 96. Signalchem Description and Business Overview
 Table 97. Signalchem Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Signalchem Cas12 Nuclease Product
 Table 99. Signalchem Recent Developments/Updates
 Table 100. BPS Bioscience Company Information
 Table 101. BPS Bioscience Description and Business Overview
 Table 102. BPS Bioscience Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. BPS Bioscience Cas12 Nuclease Product
 Table 104. BPS Bioscience Recent Developments/Updates
 Table 105. New England Biolabs Company Information
 Table 106. New England Biolabs Description and Business Overview
 Table 107. New England Biolabs Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. New England Biolabs Cas12 Nuclease Product
 Table 109. New England Biolabs Recent Developments/Updates
 Table 110. Intact Genomics Company Information
 Table 111. Intact Genomics Description and Business Overview
 Table 112. Intact Genomics Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Intact Genomics Cas12 Nuclease Product
 Table 114. Intact Genomics Recent Developments/Updates
 Table 115. Molecular Cloning Laboratories Company Information
 Table 116. Molecular Cloning Laboratories Description and Business Overview
 Table 117. Molecular Cloning Laboratories Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Molecular Cloning Laboratories Cas12 Nuclease Product
 Table 119. Molecular Cloning Laboratories Recent Developments/Updates
 Table 120. Yeasen Biotechnology Company Information
 Table 121. Yeasen Biotechnology Description and Business Overview
 Table 122. Yeasen Biotechnology Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Yeasen Biotechnology Cas12 Nuclease Product
 Table 124. Yeasen Biotechnology Recent Developments/Updates
 Table 125. Beyotime Biotech Company Information
 Table 126. Beyotime Biotech Description and Business Overview
 Table 127. Beyotime Biotech Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Beyotime Biotech Cas12 Nuclease Product
 Table 129. Beyotime Biotech Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Cas12 Nuclease Distributors List
 Table 133. Cas12 Nuclease Customers List
 Table 134. Cas12 Nuclease Market Trends
 Table 135. Cas12 Nuclease Market Drivers
 Table 136. Cas12 Nuclease Market Challenges
 Table 137. Cas12 Nuclease Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cas12 Nuclease
 Figure 2. Global Cas12 Nuclease Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cas12 Nuclease Market Share by Type: 2025 & 2032
 Figure 4. Cas12a Product Picture
 Figure 5. Cas12b Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Cas12 Nuclease Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Cas12 Nuclease Market Share by Application: 2025 & 2032
 Figure 9. Academic & Research Institutes
 Figure 10. Biopharmaceutical
 Figure 11. Hospitals & Diagnostic Centers
 Figure 12. Other
 Figure 13. Global Cas12 Nuclease Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Cas12 Nuclease Market Size (US$ Million), 2021–2032
 Figure 15. Global Cas12 Nuclease Sales (K Units), 2021–2032
 Figure 16. Global Cas12 Nuclease Average Price (US$/Unit), 2021–2032
 Figure 17. Cas12 Nuclease Report Years Considered
 Figure 18. Cas12 Nuclease Sales Share by Manufacturers in 2025
 Figure 19. Global Cas12 Nuclease Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Cas12 Nuclease Players: Market Share by Revenue in Cas12 Nuclease in 2025
 Figure 21. Cas12 Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Cas12 Nuclease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Cas12 Nuclease Sales Market Share by Country (2021–2032)
 Figure 24. North America Cas12 Nuclease Revenue Market Share by Country (2021–2032)
 Figure 25. United States Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Cas12 Nuclease Sales Market Share by Country (2021–2032)
 Figure 28. Europe Cas12 Nuclease Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Cas12 Nuclease Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Cas12 Nuclease Revenue Market Share by Region (2021–2032)
 Figure 36. China Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Cas12 Nuclease Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Cas12 Nuclease Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Cas12 Nuclease Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Cas12 Nuclease Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Cas12 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Cas12 Nuclease by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Cas12 Nuclease by Type (2021–2032)
 Figure 56. Global Cas12 Nuclease Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Cas12 Nuclease by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Cas12 Nuclease by Application (2021–2032)
 Figure 59. Global Cas12 Nuclease Price (US$/Unit) by Application (2021–2032)
 Figure 60. Cas12 Nuclease Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network